|
US6573366B1
|
|
Process for the purification of human interleukin-1 receptor antagonist from recombinant E. coli
|
|
US5882900A
|
|
Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
|
|
IL127155D0
|
|
Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli
|
|
KR20000016400A
|
|
Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli
|
|
KR20000010724A
|
|
Use of aspirochlorine or derivatives thereof as immunosuppressive agents
|
|
EP0876394A1
|
|
Preparation of (11beta,16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno 17,16-d]oxazole-3,20-dione
|
|
NZ324300A
|
|
Process for the purification of 11<beta>-21-dihydroxy-2'-methyl-5'<beta>h-pregna-1,4-dieno[17,16-d] oxazole-3,20-dione
|
|
EA000731B1
|
|
PREPARATION OF (11beta, 16 beta)-21-(3-CARBOXY-3-OXOPROPOXY)-11-HYDROXY-2'- METHYL-5'H-PREGNA-1,4-DIENO[17,16-D]OXAZOLE-3,20-DIONE
|
|
US5939523A
|
|
Purification of dalbaheptide antibiotics by isoelectric focusing
|
|
AU5900096A
|
|
Use of tropolone derivatives as inhibitors of the enzyme inositol monophospha tase
|
|
US5750509A
|
|
Amide derivatives of antibiotic A 40926
|
|
ZA9602914B
|
|
Process for the purification of glycoproteins
|
|
IL117849D0
|
|
Chromatographic process for the purification of glycoproteins
|
|
WO9624608A1
|
|
Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
|
|
AU3805295A
|
|
Microbial transformation process for obtaining antibiotic ge 2270 factor d2
|
|
AU3076695A
|
|
Dinucleoside-5',5'-pyrophosphates
|
|
CN1154112A
|
|
Dinucleoside-5',5'-pyrophosphates
|
|
US5610143A
|
|
Antibiotics GE 37468 A, B and C
|
|
US5684127A
|
|
Tetrapeptides deriving from dalbaheptide antibiotics
|
|
US5500410A
|
|
Substituted alkylamide derivatives of teicoplanin
|
